Johnson & Johnson Recalls Cerepak Aneurysm Coils After Detachment Failures

Johnson & Johnson MedTech, through its Cerenovus neurovascular business, has issued a recall of certain Cerepak detachable coil systems used in the treatment of intracranial aneurysms due to a higher-than-expected failure-to-detach rate. According to the US Food and Drug Administration (FDA), the issue has been linked to four serious injuries and one patient death reported as of 14 October.

Failure of the coils to detach properly can result in hemorrhagic or ischemic stroke, procedural delays, or the need for additional surgical intervention. J&J notified customers on 2 October, advising them to immediately remove affected products from use and return them. No action is required for devices that were successfully implanted.

The recalled devices are used for aneurysm embolization and other neurovascular and peripheral vascular procedures. There is currently no timeline for market re-availability, though J&J sales representatives are supporting customers with alternative products. 

10-02-2026